generating-imaging-mouse-human-epithelial-organoids-from-normal-tumor

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Organoids are a reliable method for modeling organ tissue due to their self-organizing properties and retention of function and architecture after ...

University of Texas Southwestern Medical Center

Poly-ADP ribose polymerase (PARP) inhibitors (PARPi) are active in patients with germline BRCA1/2 (gBRCA1/2)-mutated breast cancer, accounting for 5% to 10% of all breast cancers. Another 5% to 10% harbor somatic BRCA1/2 (sBRCA1/2) mutations or mutations in non-BRCA1/2, homologous recombination repair (HRR) genes but until recently, there were no data for the use of PARPi in these patients. This study examines the use of olaparib in patients with metastatic breast cancer harboring sBRCA1/2 or germline or somatic non-BRCA1/2, HRR mutations and demonstrates potential activity of PARPi in this setting.

Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.

Natural killer (NK) cells are innate immune cells that are critical to the body's antitumor and antimetastatic defense. As such, novel therapies are being developed to utilize NK cells as part of a next generation of immunotherapies to treat patients with metastatic disease. Therefore, it is essential for us to examine how metastatic cancer cells and NK cells interact with each other throughout the metastatic cascade. In this Review, we highlight the recent body of work that has begun to answer these questions. We explore how the unique biology of cancer cells at each stage of metastasis alters fundamental NK cell biology, including how cancer cells can evade immunosurveillance and co-opt NK cells into cells that promote metastasis. We also discuss the translational potential of this knowledge.

The changing role of natural killer cells in cancer metastasis.

Metastasis is a complex process that has been historically difficult to model in culture. Host immune responses play critical roles in restraining and promoting metastatic tumor cells. Here we describe a method of 3D organotypic co-culture of natural killer cells and tumor organoids to capture interactions between the two cellular populations. These assays can be used to model key aspects of metastatic biology and to screen for the effectiveness of agents that stimulate natural killer cell cytotoxicity.

Isaac S. Chan

Department of Internal Medicine,
Division of Hematology and Oncology,
Harold C. Simmons Comprehensive Cancer Center,
Department of Molecular Biology,
Hamon Center for Regenerative Science and Medicine,
Department of Internal Medicine, Division of Hematology and Oncology

University of Texas Southwestern Medical Center

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Isaac S. Chan

Department of Internal Medicine,Division of Hematology and Oncology,Harold C. Simmons Comprehensive Cancer Center,Department of Molecular Biology,Hamon Center for Regenerative Science and Medicine,Department of Internal Medicine, Division of Hematology and Oncology

University of Texas Southwestern Medical Center

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Department of Internal Medicine,
Division of Hematology and Oncology,
Harold C. Simmons Comprehensive Cancer Center,
Department of Molecular Biology,
Hamon Center for Regenerative Science and Medicine,
Department of Internal Medicine, Division of Hematology and Oncology